Menopausal symptoms are associated with non-adherence to highly active antiretroviral therapy in human immunodeficiency virus-infected middle-aged women

References

• Murray CJ, Ortblad KF, Guinovart C. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:1005–70
   PubMed Web of Science ®Google Scholar
• GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117–71
   PubMed Web of Science ®Google Scholar
• Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493–505
   PubMed Web of Science ®Google Scholar
• Gunthard HF, Saag MS, Benson CA, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the international antiviral Society-USA Panel. JAMA 2016;316:191–210
   PubMed Web of Science ®Google Scholar
• Chamroonsawasdi K, Insri N, Pitikultang S. Predictive factors of antiretroviral (ARV) drug adherence among people living with HIV/AIDS attending at Taksin Hospital, Bangkok, Thailand. J Med Assoc Thai 2011;94:775–81
   PubMedGoogle Scholar
• Ruanjahn G, Roberts D, Monterosso L. An exploration of factors influencing adherence to highly active anti-retroviral therapy (HAART) among people living with HIV/AIDS in Northern Thailand. AIDS Care 2010;22:1555–61
   PubMed Web of Science ®Google Scholar
• Binford MC, Kahana SY, Altice FL. A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Curr HIV/AIDS Rep 2012;9:287–312
   PubMed Web of Science ®Google Scholar
• Wasti SP, Simkhada P, Randall J, Freeman JV, van Teijlingen E. Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study. PLoS One 2012;7:e35547
   PubMed Web of Science ®Google Scholar
• Tello-Velasquez JR, Diaz-Llanes BE, Mezones-Holguin E, et al. [Poor quality of sleep associated with low adherence to highly active antiretroviral therapy in Peruvian patients with HIV/AIDS]. Cad Saude Publica 2015;31:989–1002
   PubMed Web of Science ®Google Scholar
• Dorrucci M. [Epidemiology of HIV. Update]. Recenti Prog Med 2010;101:12–15
   PubMedGoogle Scholar
• Chedraui P, Blumel JE, Baron G, et al. Impaired quality of life among middle aged women: a multicentre Latin American study. Maturitas 2008;61:323–9
   PubMed Web of Science ®Google Scholar
• Ferreira CE, Pinto-Neto AM, Conde DM, et al. Menopause symptoms in women infected with HIV: prevalence and associated factors. Gynecol Endocrinol 2007;23:198–205
   PubMed Web of Science ®Google Scholar
• Tariq S, Delpech V, Anderson J. The impact of the menopause transition on the health and wellbeing of women living with HIV: a narrative review. Maturitas 2016;88:76–83
   PubMed Web of Science ®Google Scholar
• Agaba PA, Meloni ST, Sule HM, et al. Prevalence and predictors of severe menopause symptoms among HIV-positive and -negative Nigerian women. Int J STD AIDS 2017;28:1325–34
   PubMed Web of Science ®Google Scholar
• Fumaz CR, Munoz-Moreno JA, Ferrer MJ, et al. Low levels of adherence to antiretroviral therapy in HIV-1-infected women with menstrual disorders. AIDS Patient Care STDS 2009;23:463–8
   PubMed Web of Science ®Google Scholar
• Duff PK, Money DM, Ogilvie GS, et al. Severe menopausal symptoms associated with reduced adherence to antiretroviral therapy among perimenopausal and menopausal women living with HIV in Metro Vancouver. Menopause 2018;25:531–7
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013;310:2191–4
   PubMed Web of Science ®Google Scholar
• Tafur-Valderrama E, Ortiz C, Alfaro CO, García-Jiménez E, Faus MJ. Adaptación del “Cuestionario de Evaluación de la Adhesión al Tratamiento antirretroviral” (CEAT-VIH) para su uso en Perú. Ars Pharm 2008;49:183–98
   Google Scholar
• Remor E. Valoración de la adhesión al tratamiento antirretroviral en pacientes VIH+. Psicothema 2002;14:262–7
   Google Scholar
• Remor E. Systematic review of the psychometric properties of the questionnaire to evaluate the adherence to HIV therapy (CEAT-VIH). Patient 2013;6:61–73
   PubMedGoogle Scholar
• Parraga Sandoval C, Vargas Alayza C. Asociación entre la alexitimia y la adherencia al tratamiento antirretroviral de gran actividad (targa) en personas adultas con infección por VIH/SIDA. Univ Peru Cienc Apl UPC 2016; Feb 9 [cited 2018 Nov 27]; Available from: https://repositorioacademico.upc.edu.pe/handle/10757/621606
   Google Scholar
• Aedo S, Porcile A, Irribarra C. Calidad de vida relacionada con el climaterio en una población chilena de mujeres saludables. Rev Chil Obstet Ginecol 2006;71:402–9
   Google Scholar
• Ojeda E, Monterrosa A, Blumel JE, Escobar-Lopez J, Chedraui P. Severe menopausal symptoms in mid-aged Latin American women can be related to their indigenous ethnic component. Climacteric 2011;14:157–63
   PubMed Web of Science ®Google Scholar
• Núñez-Pizarro JL, González-Luna A, Mezones-Holguin E, et al. Association between anxiety and severe quality-of-life impairment in postmenopausal women: analysis of a multicenter Latin American cross-sectional study. Menopause 2017;24:645–52
   PubMed Web of Science ®Google Scholar
• Heinemann K, Ruebig A, Potthoff P, et al. The Menopause Rating Scale (MRS) scale: a methodological review. Health Qual Life Out 2004;2:45
   PubMedGoogle Scholar
• Berlin Center for Epidemiology and Health Research. MRS – The Menopause Rating Scale: Populations reference values [Internet]. ZEGBERLIN; 2004. Available from: http://www.menopause-rating-scale.info/population.htm
   Google Scholar
• Calderon M, Galvez-Buccollini JA, Cueva G, Ordonez C, Bromley C, Fiestas F. [Validation of the Peruvian version of the PHQ-9 for diagnosing depression]. Rev Peru Med Exp Salud Publica 2012;29:578–9
   PubMedGoogle Scholar
• Harlow SD, Gass M, Hall JE, et al. STRAW + 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric 2012;15:105–14
   PubMed Web of Science ®Google Scholar
• Schaecher KL. The importance of treatment adherence in HIV. Am J Manag Care 2013;19:S231–S7
   PubMed Web of Science ®Google Scholar
• Reda AA, Biadgilign S. Determinants of Adherence to Antiretroviral Therapy among HIV-Infected patients in Africa. AIDS Res Treat 2012;2012:574656
   PubMedGoogle Scholar
• Heestermans T, Browne JL, Aitken SC, Vervoort SC, Klipstein-Grobusch K. Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review. BMJ Glob Health 2016;1:e000125
   PubMed Web of Science ®Google Scholar
• Rudy BJ, Murphy DA, Harris DR, Muenz L, Ellen J. Adolescent Trials Network for HIV/AIDS Interventions. Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactions. AIDS Patient Care STDS 2009;23:185–94
   PubMed Web of Science ®Google Scholar
• Hofler M. The Bradford Hill considerations on causality: a counterfactual perspective. Emerg Themes Epidemiol 2005;2:11
   PubMedGoogle Scholar
• Andany N, Kennedy VL, Aden M, Loutfy M. Perspectives on menopause and women with HIV. Int J Womens Health 2016;8:1–22
   PubMed Web of Science ®Google Scholar
• Puskas CM, Forrest JI, Parashar S, et al. Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011. Curr HIV/AIDS Rep 2011;8:277–87
   PubMedGoogle Scholar
• Berg KM, Demas PA, Howard AA, et al. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med 2004;19:1111–17
   PubMed Web of Science ®Google Scholar
• de Fatima Bonolo PF, Ceccato MG, Rocha GM, et al. Gender differences in non-adherence among Brazilian patients initiating antiretroviral therapy. Clinics (Sao Paulo) 2013;68:612–20
   PubMed Web of Science ®Google Scholar
• Alcalde-Rabanal JE, Lazo-Gonzalez O, Nigenda G. [The health system of Peru]. Salud Publica Mex 2011;53:S243–S54
   PubMed Web of Science ®Google Scholar
• Mezones-Holguin E, Solis-Cóndor R, Benites-Zapata VA, et al. [Institutional differences in the ineffective access to prescription medication in health care centers in Peru: analysis of the National Survey on User Satisfaction of Health Services (ENSUSALUD 2014)]. Rev Peru Med Exp Salud Publica 2016;33:205–14
   PubMedGoogle Scholar
• Alvis Ó, Coll LD, Chumbimune L, Díaz C, Díaz J, Reyes M. Factores asociados a la no adherencia al tratamiento antirretroviral de gran actividad en adultos infectados con el VIH-sida. An Fac Med 2012;70:266–72
   Google Scholar
• Pacifico J, Gutierrez C. [Information about the medicines and adherence to high activity antiretroviral treatment in patients with HIV/AIDS in a hospital of Lima, Peru]. Rev Peru Med Exp Salud Publica 2015;32:66–72
   PubMedGoogle Scholar
• Looby SE, Shifren J, Corless I, et al. Increased hot flash severity and related interference in perimenopausal human immunodeficiency virus-infected women. Menopause 2014;21:403–9
   PubMed Web of Science ®Google Scholar
• Tepper PG, Brooks MM, Randolph JF, Jr, et al. Characterizing the trajectories of vasomotor symptoms across the menopausal transition. Menopause 2016;23:1067–74
   PubMed Web of Science ®Google Scholar
• Kole AK, Roy R, Kole DC. Musculoskeletal and rheumatological disorders in HIV infection: experience in a tertiary referral center. Indian J Sex Transm Dis AIDS 2013;34:107–12
   PubMedGoogle Scholar
• Valadares AL, Pinto-Neto AM, Gomes Dde C, et al. Dyspareunia in HIV-positive and HIV-negative middle-aged women: a cross-sectional study. BMJ Open 2014;4:e004974
   PubMedGoogle Scholar
• Trotta MP, Ammassari A, Murri R, et al. Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals. AIDS Patient Care STDS 2008;22:291–99
   PubMed Web of Science ®Google Scholar
• Rubin LH, Sundermann EE, Cook JA, et al. Investigation of menopausal stage and symptoms on cognition in human immunodeficiency virus-infected women. Menopause 2014;21:997–1006
   PubMed Web of Science ®Google Scholar
• Maki PM, Rubin LH, Cohen M, et al. Depressive symptoms are increased in the early perimenopausal stage in ethnically diverse human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Menopause 2012;19:1215–23
   PubMed Web of Science ®Google Scholar
• Olisah VO, Baiyewu O, Sheikh TL. Adherence to highly active antiretroviral therapy in depressed patients with HIV/AIDS attending a Nigerian university teaching hospital clinic. Afr J Psychiatry (Johannesbg) 2010;13:275–9
   PubMedGoogle Scholar
• Bull L, Tittle V, Rashid T, Nwokolo N. HIV and the menopause: A review. Post Reprod Health 2018;24:19–25
   PubMedGoogle Scholar
• National AIDS Plan (PNS), AIDS Study Group (GeSIDA). Executive summary of the consensus statement on assistance to women with HIV infection in the health care sector. National AIDS Plan (PNS) and AIDS Study Group (GeSIDA). Enferm Infecc Microbiol Clin 2014;32:100–5
   PubMed Web of Science ®Google Scholar